CD8A and neoplasm: Furthermore, the blockade of CTLA-4 in mice intraperitoneally infected with transgenic T. cruzi enhanced the anti-tumor immune process by promiting the activation of NY-ESO-1 specific CD8+ T cells, increasing their IFN-γ expression, and enhancing their infiltration into the TME (Dos Santos et al., 2015).